The mean of analysts' price targets for Crescent Energy (CRGY) points to a 67.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

The average of price targets set by Wall Street analysts indicates a potential upside of 303.5% in Day One Biopharmaceuticals (DAWN). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

The consensus price target hints at a 72.3% upside potential for Immunocore (IMCR). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

The average of price targets set by Wall Street analysts indicates a potential upside of 25.2% in On Holding (ONON). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Commvault (CVLT) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

Concrete Pumping Holdings remains a "strong buy" despite recent share gains, as it trades cheaply relative to peers and its own cash flows. Short-term weakness is expected due to economic headwinds, high interest rates, and softer construction activity, but the long-term trajectory is positive. The company's asset-light business model, market leadership, and growth potential in Eco-Pan and infrastructure projects support its investment appeal.

ServiceNow Inc. CEO Bill McDermott says artificial intelligence is helping save on labor costs and making the company faster. “We're slowing down the hiring in jobs that are — quite frankly — soul crushing jobs," McDermott said on Bloomberg Tech.

Core Laboratories Inc. (NYSE:CLB ) Q2 2025 Earnings Conference Call July 24, 2025 8:30 AM ET Company Participants Christopher Scott Hill - Senior VP & CFO Gwendolyn Y. Gresham - Senior Vice President of Corporate Development & Investor Relations Lawrence V.

IBM (IBM) shares sank in intraday trading Thursday, as slightly weaker-than-expected software revenue growth is weighing on a second-quarter earnings report that largely topped estimates.

TTE's second-quarter earnings miss estimates due to year-over-year declining oil prices.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Ladder Capital (LADR) came out with quarterly earnings of $0.23 per share, beating the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.31 per share a year ago.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Imax (IMAX) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.18 per share a year ago.

Phinia (PHIN) came out with quarterly earnings of $1.27 per share, beating the Zacks Consensus Estimate of $0.99 per share. This compares to earnings of $0.88 per share a year ago.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Align Technology (ALGN) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, ALGN broke through the 200-day moving average, which suggests a long-term bullish trend.

From a technical perspective, United Therapeutics (UTHR) is looking like an interesting pick, as it just reached a key level of support. UTHR recently overtook the 50-day moving average, and this suggests a short-term bullish trend.